SMT201500303B - Ammine in c-28 di derivati dell'acido betulinico modificati in c-3 come inibitori della maturazione dell' hiv - Google Patents

Ammine in c-28 di derivati dell'acido betulinico modificati in c-3 come inibitori della maturazione dell' hiv

Info

Publication number
SMT201500303B
SMT201500303B SM201500303T SM201500303T SMT201500303B SM T201500303 B SMT201500303 B SM T201500303B SM 201500303 T SM201500303 T SM 201500303T SM 201500303 T SM201500303 T SM 201500303T SM T201500303 B SMT201500303 B SM T201500303B
Authority
SM
San Marino
Prior art keywords
ammines
inhibitors
acid derivatives
betulinic acid
derivatives modified
Prior art date
Application number
SM201500303T
Other languages
English (en)
Italian (it)
Inventor
Alicia Regueiro-Ren
Jacob Swidorski
Sing-Yuen Sit
Yan Chen
Jie Chen
Nicholas A Meanwell
Zheng Liu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of SMT201500303B publication Critical patent/SMT201500303B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SM201500303T 2011-01-31 2015-12-01 Ammine in c-28 di derivati dell'acido betulinico modificati in c-3 come inibitori della maturazione dell' hiv SMT201500303B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161437870P 2011-01-31 2011-01-31
PCT/US2012/022847 WO2012106188A1 (en) 2011-01-31 2012-01-27 C-28 amines of c-3 modified betulinic acid derivatives as hiv maturation inhibitors

Publications (1)

Publication Number Publication Date
SMT201500303B true SMT201500303B (it) 2016-01-08

Family

ID=45567146

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201500303T SMT201500303B (it) 2011-01-31 2015-12-01 Ammine in c-28 di derivati dell'acido betulinico modificati in c-3 come inibitori della maturazione dell' hiv

Country Status (19)

Country Link
US (1) US8748415B2 (OSRAM)
EP (1) EP2670764B1 (OSRAM)
JP (1) JP6000283B2 (OSRAM)
CN (1) CN103339141B (OSRAM)
BR (1) BR112014010105A2 (OSRAM)
CA (1) CA2826257A1 (OSRAM)
CY (1) CY1116989T1 (OSRAM)
DK (1) DK2670764T3 (OSRAM)
EA (1) EA023578B1 (OSRAM)
ES (1) ES2552512T3 (OSRAM)
HR (1) HRP20151212T1 (OSRAM)
HU (1) HUE026371T2 (OSRAM)
MX (1) MX2013008359A (OSRAM)
PL (1) PL2670764T3 (OSRAM)
PT (1) PT2670764E (OSRAM)
RS (1) RS54352B1 (OSRAM)
SI (1) SI2670764T1 (OSRAM)
SM (1) SMT201500303B (OSRAM)
WO (1) WO2012106188A1 (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014006559A2 (pt) 2011-09-21 2017-03-28 Bristol Myers Squibb Co derivados do ácido betulínico com atividade antiviral
US8906889B2 (en) * 2012-02-15 2014-12-09 Bristol-Myers Squibb Company C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity
US8889854B2 (en) 2012-05-07 2014-11-18 Bristol-Myers Squibb Company C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
RU2516952C1 (ru) * 2012-11-09 2014-05-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая инкапсулированную тритерпеновую кислоту или ее производные
RU2519133C1 (ru) * 2012-11-09 2014-06-10 Леонид Леонидович Клопотенко Мазь, содержащая инкапсулированную тритерпеновую кислоту или ее производные
CN103214543B (zh) * 2012-12-25 2015-09-02 中国人民解放军海军医学研究所 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用
SG11201505639SA (en) * 2013-02-06 2015-08-28 Bristol Myers Squibb Co C-19 modified triterpenoids with hiv maturation inhibitory activity
MX2015010354A (es) 2013-02-25 2015-10-09 Squibb Bristol Myers Co Derivados de acido betulinico modificados con aquilo c-3 y alquenilo utiles en el tratamiento de virus de inmunodeficiencia humana (vih).
PL3129392T3 (pl) 2014-04-11 2021-04-06 VIIV Healthcare UK(No.4) Limited Triterpenoidy o aktywności hamującej dojrzewanie hiv, podstawione w pozycji 3 niearomatycznym pierścieniem zawierającym podstawnik fluorowcoalkilowy
WO2015195776A1 (en) * 2014-06-19 2015-12-23 Bristol-Myers Squibb Company Betulinic acid derivatives with hiv maturation inhibitory activity
US10047118B2 (en) 2014-11-14 2018-08-14 VIIV Healthcare UK (No.5) Limited C17-aryl substituted betulinic acid analogs
CN107250151A (zh) * 2014-11-14 2017-10-13 Viiv保健英国第五有限公司 扩展的桦木酸类似物
US9969767B2 (en) 2014-11-14 2018-05-15 VIIV Healthcare UK (No.5) Limited Oxolupene derivatives
US10221208B2 (en) * 2015-04-14 2019-03-05 ViiV Healthcare UK (No.4) Limited Methods of producing an HIV maturation inhibitor
WO2017017609A1 (en) 2015-07-28 2017-02-02 Glaxosmithkline Intellectual Property (No.2) Limited Betuin derivatives for preventing or treating hiv infections
CA2993758A1 (en) * 2015-07-28 2017-02-02 Glaxosmithkline Intellectual Property (No.2) Limited Betuin derivatives for preventing or treating hiv infections
AU2016327169A1 (en) 2015-09-24 2018-04-12 Glaxosmithkline Intellectual Property (No.2) Limited Compounds with hiv maturation inhibitory activity
EP3405474A1 (en) 2016-01-20 2018-11-28 Glaxosmithkline Intellectual Property (No. 2) Limited Amine derivatives of lupanes with hiv maturation inhibitory activity
AR107512A1 (es) 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
WO2018002849A1 (en) * 2016-06-30 2018-01-04 VIIV Healthcare UK (No.5) Limited Triterpenoid inhibitors of human immunodeficiency virus replication
IL273078B2 (en) * 2017-09-13 2025-06-01 Emmyon Inc Ursolic acid morpholine and diethanolamine salts
EP3681477A4 (en) 2017-09-14 2021-06-09 Phoenix Biotechnology, Inc. PROCEDURES AND IMPROVED COMPOSITION FOR TREATMENT OF TREITERPEN RESPONSIBLE CONDITIONS, DISEASES, OR DISORDERS
RU2020113341A (ru) 2017-09-14 2021-10-15 Феникс Байотекнолоджи, Инк. Способ и композиция для лечения вирусной инфекции
EP4321164A3 (en) 2018-04-24 2024-04-17 ViiV Healthcare UK (No.5) Limited Compounds with hiv maturation inhibitory activity
PL237998B1 (pl) 2018-05-28 2021-06-28 Narodowy Inst Lekow Fosfonowe pochodne kwasu 3-karboksyacylobetulinowego, sposób ich otrzymywania oraz ich zastosowanie
US10343997B1 (en) 2018-12-04 2019-07-09 King Saud University Ursolic acid derivatives
EP4295854A3 (en) 2020-03-31 2024-04-03 Phoenix Biotechnology, Inc. Method and compositions for treating coronavirus infection
JP7153083B2 (ja) 2020-03-31 2022-10-13 フェニックス・バイオテクノロジー・インコーポレイテッド コロナウイルス感染を治療するための方法および組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5413999A (en) 1991-11-08 1995-05-09 Merck & Co., Inc. HIV protease inhibitors useful for the treatment of AIDS
US5869535A (en) 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
US5962527A (en) 1995-03-21 1999-10-05 The Board Of Trustees Of The University Of Illinois Method and composition for treating cancers
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
US20040110785A1 (en) 2001-02-02 2004-06-10 Tao Wang Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
US7365221B2 (en) 2002-09-26 2008-04-29 Panacos Pharmaceuticals, Inc. Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof
WO2004089357A2 (en) 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Anti-fungal formulation of triterpene and essential oil
US7745625B2 (en) 2004-03-15 2010-06-29 Bristol-Myers Squibb Company Prodrugs of piperazine and substituted piperidine antiviral agents
MXPA06010592A (es) 2004-03-17 2007-06-12 Panacos Pharmaceuticals Inc Sales farmaceuticas de acido 3-o-(3',3'-dimetilsuccinil) betulinico.
CN101142227A (zh) * 2004-11-12 2008-03-12 帕纳克斯医药公司 新颖的桦木醇衍生物、其制备和其用途
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
WO2008127364A2 (en) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
US20110144069A1 (en) 2006-10-16 2011-06-16 Myriad Genetics, Incorporated Compounds for treating viral infections
EP2257567A1 (en) 2008-02-14 2010-12-08 Virochem Pharma Inc. Novel 17 beta lupane derivatives
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
MX2012013628A (es) * 2010-06-04 2012-12-17 Bristol Myers Squibb Co Amidas c-28 de derivados del acido betulinico c-3 modificados como inhibidores de la maduracion del virus de inmunodeficiencia humana (vih).
CN103038245B (zh) * 2010-06-04 2015-03-25 百时美施贵宝公司 作为hiv成熟抑制剂的c-3经修饰的桦木酸衍生物
US8846647B2 (en) * 2011-01-31 2014-09-30 Bristol-Myers Squibb Company C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity

Also Published As

Publication number Publication date
CN103339141B (zh) 2016-08-24
WO2012106188A1 (en) 2012-08-09
HRP20151212T1 (hr) 2015-12-04
BR112014010105A2 (pt) 2017-06-13
US8748415B2 (en) 2014-06-10
CA2826257A1 (en) 2012-08-09
PT2670764E (pt) 2015-11-20
RS54352B1 (sr) 2016-02-29
MX2013008359A (es) 2013-08-27
JP6000283B2 (ja) 2016-09-28
DK2670764T3 (en) 2015-12-07
ES2552512T3 (es) 2015-11-30
EA201391098A1 (ru) 2013-12-30
CY1116989T1 (el) 2017-04-05
EP2670764B1 (en) 2015-09-02
JP2014507422A (ja) 2014-03-27
EA023578B1 (ru) 2016-06-30
EP2670764A1 (en) 2013-12-11
US20130029954A1 (en) 2013-01-31
HUE026371T2 (en) 2016-05-30
CN103339141A (zh) 2013-10-02
SI2670764T1 (sl) 2016-03-31
PL2670764T3 (pl) 2016-02-29

Similar Documents

Publication Publication Date Title
SMT201500303B (it) Ammine in c-28 di derivati dell'acido betulinico modificati in c-3 come inibitori della maturazione dell' hiv
SMT201500272B (it) Ammidi in c-28 di derivati dell'acido betulinico modificati in c-3 come inibitori della maturazione dell'hiv"
EP2576585B8 (en) Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
SI2683731T1 (sl) C4-monometil triterpenoidni derivati in postopki njihove uporabe
IL240739A0 (en) Derivatives of betulinic acid that are modified by c-3 alkyl and alkenyl used to treat HIV
PL2755508T3 (pl) Artykuł do palenia i jego produkcja
PL2787094T3 (pl) Materiał stopu aluminium i struktura stopu aluminium i proces ich wytwarzania
IL233081A (en) History of Batolin
EP2670527A4 (en) PROCESS FOR THE PREPARATION OF COMPLETE MONOLAYER OF PLATINUM ON NANOPARTICLES OF PALLADIUM CORES
IL231421A0 (en) Innovative derivatives of betulinic acid with antiviral activity
FI20116334L (fi) Eukaryottiset solut ja menetelmä glykolihapon valmistamiseksi
ZA201403431B (en) Pharmaceutical compositions and methods of use of 4-pregenen-11b-21-triol-3,20-dione derivatives
EP2791102A4 (en) PROPENOATE DERIVATIVES OF BETULIN
BR112013022254A2 (pt) método e disposição para gerar oxigênio
EP2723853A4 (en) CARDIOVASCULAR IN VITRO MODEL
EP2785836A4 (en) IMPROVED MANUFACTURE OF CITRIC ACID IN ASPERGILLUS
ZA201203821B (en) In vitro anti-sickling activity of betulinic acid, oleanolic acid and their derivatives
GB2484780B (en) Wristband with torch and other facilities provision
EP2610252A4 (en) NOVEL PROCESS FOR THE PRODUCTION OF ISOQUINOLINE DERIVATIVES AND THEIR SALTS
IL233586A0 (en) Using avocado peels to obtain material from avocados that cannot be turned into soap enriched with saturated aliphatic hydrocarbons and sterols
PT2689070T (pt) Poste flexível de chapa metálica fina e processo de organizar a iluminação pública
PL2735384T3 (pl) Sztaba z metalu szlachetnego i sposób wytwarzania
EE201100041A (et) Mittetstotoksiline alfaviiruskonstrukt, rakuliin ja kompositsioon ning meetod viirusvastaste hendite m?ju tuvastamiseks
IT1405012B1 (it) Composizioni di beclometasone dipropionato in microsfere gastroresistenti a rilascio modificato e processo per il loro ottenimento
PL394078A1 (pl) Kompozycja produktu spożywczego i sposób wytwarzania kompozycji produktu spożywczego